Q89.9Congenital malformation, unspecified

Q89.9 is the ICD-10-CM diagnosis code for congenital malformation, unspecified. It belongs to category Q89 (other congenital malformations, not elsewhere classified), block Q80-Q89 (other congenital malformations) and chapter 17 (congenital malformations, deformations, chromosomal abnormalities, and genetic disorders). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within Q89, choose Q89.9 (Congenital malformation, unspecified) only when documentation doesn't support a more specific option: congenital absence and malformations of spleen (Q89.0), congenital malformations of adrenal gland (Q89.1), congenital malformations of other endocrine glands (Q89.2), Situs inversus (Q89.3), conjoined twins (Q89.4), multiple congenital malformations, not elsewhere classified (Q89.7) and other specified congenital malformations (Q89.8).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 951 (Other Factors Influencing Health Status, relative weight 0.5577), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 759.9 (congenital anomaly, unspecified).